← Back to Screener
Align Technology Inc (ALGN)
Price$167.74
Value ScoreB
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)6.04%
Price vs S&P 500 (4W)-0.61%
VGM Score52.02
Market Capitalization$12.01B
P/E Ratio (Annual)29.28x
All Metrics
P/CF (Annual)20.25x
Book Value / Share (Quarterly)$57.94
P/TBV (Annual)2.83x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)2.61%
Cash Flow / Share (Quarterly)$8.15
Price vs S&P 500 (YTD)-0.74%
Gross Margin (TTM)68.58%
Net Profit Margin (TTM)10.50%
EPS (TTM)$5.97
10-Day Avg Trading Volume1.03M
EPS Excl Extra (TTM)$5.97
Revenue Growth (5Y)10.30%
EPS (Annual)$5.65
ROI (Annual)10.13%
Gross Margin (Annual)68.27%
Net Profit Margin (5Y Avg)12.29%
Cash / Share (Quarterly)$14.80
P/E Basic Excl Extra (TTM)27.94x
Revenue Growth QoQ (YoY)6.21%
EPS Growth (5Y)-24.09%
P/E Normalized (Annual)29.28x
ROA (Last FY)6.58%
Revenue Growth TTM (YoY)2.89%
EBITD / Share (TTM)$11.26
ROE (5Y Avg)12.94%
Operating Margin (TTM)13.59%
Cash Flow / Share (Annual)$6.88
P/B Ratio2.90x
P/B Ratio (Quarterly)2.96x
Net Income / Employee (Annual)$20,200
EV / Revenue (TTM)2.68x
Net Interest Coverage (TTM)38.91x
ROA (TTM)6.88%
EPS Growth QoQ (YoY)24.33%
EV / EBITDA (TTM)13.52x
EPS Incl Extra (Annual)$5.65
Current Ratio (Annual)1.36x
Quick Ratio (Quarterly)1.22x
3-Month Avg Trading Volume1.20M
52-Week Price Return-6.95%
EV / Free Cash Flow (Annual)22.35x
P/E Incl Extra (TTM)27.94x
Revenue / Employee (TTM)$201,900
Tangible BV / Share (Quarterly)$56.53
P/S Ratio (Annual)2.98x
Asset Turnover (Annual)0.65x
52-Week High$208.31
Operating Margin (5Y Avg)17.68%
EPS Excl Extra (Annual)$5.65
CapEx CAGR (5Y)-7.94%
Tangible BV CAGR (5Y)4.97%
26-Week Price Return13.96%
Quick Ratio (Annual)1.21x
13-Week Price Return-4.48%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.39x
Enterprise Value$10.97B
Revenue / Share Growth (5Y)12.24%
Asset Turnover (TTM)0.66x
Book Value / Share Growth (5Y)6.72%
Revenue / Employee (Annual)$198,900
Inventory Turnover (Annual)5.33x
Pretax Margin (Annual)14.51%
Cash / Share (Annual)$15.34
3-Month Return Std Dev42.45%
Gross Margin (5Y Avg)70.63%
Net Income / Employee (TTM)$21,200
EBITDA CAGR (5Y)10.26%
EBITDA Interim CAGR (5Y)-7.58%
ROE (Last FY)10.13%
Net Interest Coverage (Annual)15.41x
EPS Basic Excl Extra (Annual)$5.65
P/FCF (TTM)20.58x
Receivables Turnover (TTM)3.75x
EV / Free Cash Flow (TTM)18.79x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$5.97
Receivables Turnover (Annual)3.85x
ROI (TTM)10.70%
P/S Ratio (TTM)2.93x
Pretax Margin (5Y Avg)17.60%
Revenue / Share (Annual)$55.59
Tangible BV / Share (Annual)$55.42
Forward P/E14.88x
Free OCF CAGR (5Y)-0.66%
Price vs S&P 500 (52W)-31.31%
P/E Ratio (TTM)27.94x
EPS Growth TTM (YoY)8.83%
Year-to-Date Return7.42%
5-Day Price Return-1.20%
EPS Normalized (Annual)$5.65
ROA (5Y Avg)7.95%
Net Profit Margin (Annual)10.17%
Month-to-Date Return-4.12%
Cash Flow / Share (TTM)$6.55
EBITD / Share (Annual)$10.79
EPS Growth (3Y)7.02%
Operating Margin (Annual)13.53%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)17.37x
ROI (5Y Avg)12.94%
P/E Excl Extra (TTM)27.94x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$5.97
P/TBV (Quarterly)3.03x
P/B Ratio (Annual)2.77x
Inventory Turnover (TTM)5.58x
Pretax Margin (TTM)14.50%
Book Value / Share (Annual)$56.74
Price vs S&P 500 (13W)-12.73%
Net Margin Growth (5Y)-32.36%
Beta1.64x
P/FCF (Annual)24.48x
Revenue / Share (TTM)$57.19
ROE (TTM)10.70%
52-Week Low$122.00
vGradeB
gGradeC
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 262.58est. 2.33
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.88
3.92
3.96
4.00
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ALGNAlign Technology Inc | B | C | C | $167.74 |
| ISRGIntuitive Surgical Inc. | F | B | C | $422.06 |
| EWEdwards Lifesciences Corp | D | C | C | $85.96 |
| STESTERIS plc | C | B | C | $212.35 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $87.33 |
| SNNSmith & Nephew plc | B | C | C | $30.61 |
| MSAMine Safety Incorporated | B | C | C | $161.30 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $74.31 |
| ENOVEnovis Corporation | B | D | C | $23.78 |
| CDRECadre Holdings, Inc. | C | C | D | $30.01 |
| AVNSAvanos Medical, Inc. | B | D | A | $25.05 |
About
Align Technology dominates the clear aligner market with Invisalign, which controls over 90% market share since FDA approval in 1998 and can treat approximately 90% of malocclusion cases. The platform has achieved significant scale with 14+ million cumulative patients and treated over 2 million cases in 2022 alone. The company strengthens its ecosystem with iTero intraoral scanners, which capture digital impressions for over half of Invisalign treatments.